Table 1

Demographic characteristics of patients admitted with community-acquired pneumonia

Normocapnia (PaCO2 35–45 mm Hg)Hypocapnia (PaCO2 <35 mm Hg)Hypercapnia (PaCO2 >45 mm Hg)p Value
Total patients
(n=295)
57 (19.32%)181 (61.35%)57 (19.32%)
Mean age (years)61.14±13.8558.18±18.9765.77±11.370.18
Gender
 Men18 (31.57%)108 (59.66%)31 (54.38%)0.08
 Women39 (68.42%)73 (40.33%)26 (45.61%)
Season
 January to April24 (42.1%)53 (29.3%)34 (59.6%)0.001
 May to August14 (24.6%)57 (31.5%)8 (14%)
 September to December19 (33.3%)71 (39.2%)15 (26.3%)
Comorbid 
Diabetes
23 (40.35%)50 (27.62%)25 (43.9%)0.03
IHD18 (31.57%)33 (18.23%)14 (24.6%)0.04
HTN27 (47.4%)68 (37.6%)27 (47.4%)0.25
COPD04 (2.2%)11 (19.3%)<0.001
Asthma3 (5.3%)25 (13.8%)10 (17.5%)0.12
pH
 <7.355 (8.7%)8 (4.4%)35 (61.40%)<0.001
 >7.3552 (91.22%)173 (95.58%)22 (38.59%)
PaOlevel (mean)69.13±17.9871.68±20.1678.45±350.37
PaCO2 level (mean)37.05±3.6530.66±9.5465.36±18.94<0.001
Serum creatinine
 <136 (63.15%)59 (32.59%)15 (26.31%)0.01
 >121 (36.84%)122 (67.40%)42 (73.68%)
CURB65 (mean±SD)2.0±1.062.37±1.143.14±1.280.004
PSI (mean±SD)66.36±32.472.39±29.4695.68±29.120.002
Chest X-ray infiltrates
 Unilateral35 (61.4%)118 (65.2%)26 (45.6%)0.03
 Bilateral22 (38.6%)63 (34.8%)31 (54.4%)
Use of steroids
(systemic)
 Yes27 (47.4%)73 (40.3%)42 (73.7%) <0.001
30 (52.6%)108 (59.7%)15 (26.3%)
NIMV therapy
 ER15 (26.3%)112 (61.8%)50 (87.71%)0.03
 SCU15 (24.5%)94 (51.93%)45 (78.94%)
 ICU000
 NIMV failure in ER018 (9.9%)5 (8.7%)
TCS 
(mean±SD), days
2.76±2.13.17±1.994.39±2.00.03
  •  COPD, chronic obstructive pulmonary disease; ER, emergency room; HTN, hypertension; IHD, ischaemic heart disease; NIMV, non-invasive mechanical failure; PSI, pneumonia severity index ; SCU , special care unit TCS, time to clinical stability.